Long non-coding RNA and microRNAs might act in regulating the expression of BARD1 mRNAs

International Journal of Biochemistry and Cell Biology

Volumn 54, Issue , 2014, Pages 356-367

  Pilyugin, Maxim ^a   Irminger Finger, Irmgard ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Alternative splicing; ceRNA; lncRNA; microRNA; Neuroblastoma SNP

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; LONG UNTRANSLATED RNA; MESSENGER RNA; MICRORNA; MICRORNA 101; MICRORNA 203; RNA ISOFORM; SPACER DNA; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; BARD1 PROTEIN, HUMAN; ISOPROTEIN; RNA; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE;

3' UNTRANSLATED REGION; ARTICLE; ARTIFACT; BINDING SITE; CANCER GROWTH; CARCINOGENESIS; CHROMOSOME DELETION; CODON; CPG ISLAND; DOWN REGULATION; EPIGENETICS; EXON; EXON SKIPPING; GENE ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC CODE; GENOTYPE; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; MOLECULAR RECOGNITION; POLYADENYLATION; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; START CODON; STOP CODON; TRANSCRIPTION INITIATION SITE; TRANSLATION INITIATION; UPREGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; RNA, MESSENGER; RNA, NEOPLASM; SEQUENCE HOMOLOGY, NUCLEIC ACID; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 84925341738     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2014.06.018     Document Type: Article

References (73)

1. V. Ambros The functions of animal microRNAs Nature 431 7006 2004 350 355
2. I. Behm-Ansmant, J. Rehwinkel, T. Doerks, A. Stark, P. Bork, and E. Izaurralde mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes Genes Dev 20 14 2006 1885 1898
3. E. Birney, J.A. Stamatoyannopoulos, A. Dutta, R. Guigó, T.R. Gingeras, and E.H. Margulies Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project Nature 447 7146 2007 799 816
4. K.R. Bosse, S.J. Diskin, K.A. Cole, A.C. Wood, R.W. Schnepp, and G. Norris Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity Cancer Res 72 8 2012 2068 2078
5. C.J. Brown, A. Ballabio, J.L. Rupert, R.G. Lafreniere, M. Grompe, and R. Tonlorenzi A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome Nature 349 6304 1991 38 44
6. J. Buechner, E. Tømte, B.H. Haug, J.R. Henriksen, C. Løkke, and T. Flægstad Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma Br J Cancer 105 2 2011 296 303
7. M.J. Bueno, I. Pérez de Castro, M. Gómez de Cedrón, J. Santos, G.A. Calin, and J.C. Cigudosa Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression Cancer Cell 13 6 2008 496 506
8. M. Capasso, M. Devoto, C. Hou, S. Asgharzadeh, J.T. Glessner, and E.F. Attiyeh Common variations in BARD1 influence susceptibility to high-risk neuroblastoma Nat Genet 41 6 2009 718 723
9. P. Carninci, T. Kasukawa, S. Katayama, J. Gough, M.C. Frith, and N. Maeda The transcriptional landscape of the mammalian genome Science 309 5740 2005 1559 1563
10. Y. Chiang, Y. Song, Z. Wang, Y. Chen, Z. Yue, and H. Xu Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers J Gastrointest Surg 15 1 2011 63 70
11. A.L. Creekmore, Y.S. Ziegler, J.L. Bonéy, and A.M. Nardulli Estrogen receptor alpha regulates expression of the breast cancer 1 associated ring domain 1 (BARD1) gene through intronic DNA sequence Mol Cell Endocrinol 267 1-2 2007 106 115
12. C.M. Croce Causes and consequences of microRNA dysregulation in cancer Nat Rev Genet 10 10 2009 704 714
13. T. Derrien, R. Johnson, G. Bussotti, A. Tanzer, S. Djebali, and H. Tilgner The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression Genome Res 22 9 2012 1775 1789
14. M.E. Dinger, K.C. Pang, T.R. Mercer, M.L. Crowe, S.M. Grimmond, and J.S. Mattick NRED: a database of long noncoding RNA expression Nucleic Acids Res 37 Suppl 1 2009 D122 D126
15. E. Dizin, and I. Irminger-Finger Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1 Int J Biochem Cell Biol 42 5 2010 693 700
16. A. Feber, L. Xi, J.D. Luketich, A. Pennathur, R.J. Landreneau, and M. Wu MicroRNA expression profiles of esophageal cancer J Thorac Cardiovasc Surg 135 2 2008 255 260 (discussion 260)
17. A. Feki, C.E. Jefford, P. Berardi, J.-Y. Wu, L. Cartier, and K.-H. Krause BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase Oncogene 24 23 2005 3726 3736
18. M. Furuta, K. Kozaki, S. Tanaka, S. Arii, I. Imoto, and J. Inazawa miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma Carcinogenesis 31 5 2010 766 776
19. R. Garzon, G. Marcucci, and C.M. Croce Targeting microRNAs in cancer: rationale, strategies and challenges Nat Rev Drug Discovery 9 10 2010 775 789
20. A. Gaur, D.A. Jewell, Y. Liang, D. Ridzon, J.H. Moore, and C. Chen Characterization of microRNA expression levels and their biological correlates in human cancer cell lines Cancer Res 67 6 2007 2456 2468
21. I.K. Guttilla, K.N. Phoenix, X. Hong, J.S. Tirnauer, K.P. Claffey, and B.A. White Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs Breast Cancer Res Treat [Internet] 2011 Available from http://www.ncbi.nlm.nih.gov/pubmed/21553120 [accessed 2011 Jun 21]
22. Y. Hao, X. Gu, Y. Zhao, S. Greene, W. Sha, and D.T. Smoot Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo Cancer Prev Res (Phila) 4 7 2011 Jul 1073 1083
23. R. Hashizume, M. Fukuda, I. Maeda, H. Nishikawa, D. Oyake, and Y. Yabuki The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation J Biol Chem 276 18 2001 14537 14540
24. S. He, S. Liu, and H. Zhu The sequence, structure and evolutionary features of HOTAIR in mammals BMC Evol Biol 11 2011 102
25. I. Irminger-Finger, and C.E. Jefford Is there more to BARD1 than BRCA1? Nat Rev Cancer 6 5 2006 382 391
26. I. Irminger-Finger, J.V. Soriano, G. Vaudan, R. Montesano, and A.P. Sappino In vitro repression of Brca1-associated RING domain gene, Bard1, induces phenotypic changes in mammary epithelial cells J Cell Biol 143 5 1998 1329 1339
27. Y. Jin, X.L. Xu, M.C. Yang, F. Wei, T.C. Ayi, and A.M. Bowcock Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains Proc Nat Acad Sci USA 94 22 1997 12075 12080
28. V. Joukov, A.C. Groen, T. Prokhorova, R. Gerson, E. White, and A. Rodriguez The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly Cell 127 3 2006 539 552
29. P. Kapranov, J. Cheng, S. Dike, D.A. Nix, R. Duttagupta, and A.T. Willingham RNA maps reveal new RNA classes and a possible function for pervasive transcription Science 316 5830 2007 1484 1488
30. D.H. Larsen, C. Poinsignon, T. Gudjonsson, C. Dinant, M.R. Payne, and F.J. Hari The chromatin-remodeling factor CHD4 coordinates signaling and repair after DNA damage J Cell Biol 190 5 2010 731 740
31. V. Latorre, S.J. Diskin, M.A. Diamond, H. Zhang, H. Hakonarson, and J.M. Maris Replication of neuroblastoma SNP association at the BARD1 locus in African-Americans Cancer Epidemiol Biomarkers Prev 21 4 2012 658 663
32. M. Laufer, S.V. Nandula, A.P. Modi, S. Wang, M. Jasin, and V.V.V.S. Murty Structural requirements for the BARD1 tumor suppressor in chromosomal stability and homology-directed DNA repair J Biol Chem 282 47 2007 Nov 34325 34333
33. Y.H. Lee, J.-H. Kim, and G.G. Song Genome-wide pathway analysis in neuroblastoma Tumour Biol 2013
34. I. Lepore, C. Dell'Aversana, M. Pilyugin, M. Conte, A. Nebbioso, and F. De Bellis HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or b PLoS One 2013
35. S. Leung-Kuen Au, C. Chak-Lui Wong, J. Man-Fong Lee, D. Ngo-Yin Fan, F. Hoching Tsang, and I. Oi-Lin Ng Enhancer of zeste homolog 2 (EZH2) epigenetically silences multiple tumor suppressor miRNAs to promote liver cancer metastasis Hepatology (Baltimore, Md) [Internet] 2012 Feb Available from: http://www.ncbi.nlm.nih.gov/pubmed/22370893 [accessed from 2012 Mar 26]
36. L. Li, M. Cohen, J. Wu, M.H. Sow, B. Nikolic, and P. Bischof Identification of BARD1 splice-isoforms involved in human trophoblast invasion Int J Biochem Cell Biol 39 9 2007 1659 1672
37. L. Li, S. Ryser, E. Dizin, D. Pils, M. Krainer, and C.E. Jefford Oncogenic BARD1 isoforms expressed in gynecological cancers Cancer Res 67 24 2007 Dec 11876 11885
38. M. Li, and X. Yu Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation Cancer Cell 23 5 2013 May 693 704
39. G. Lombardi, E. Falaschi, C. Di Cristofano, A.G. Naccarato, E. Sensi, and P. Aretini Identification of novel alternatively spliced BRCA1-associated RING domain (BARD1) messenger RNAs in human peripheral blood lymphocytes and in sporadic breast cancer tissues Genes Chromosom Cancer 46 9 2007 791 795
40. L. Luo, T. Zhang, H. Liu, T. Lv, D. Yuan, and Y. Yao MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance Med Oncol [Internet] 2011 Available from: http://www.ncbi.nlm.nih.gov/pubmed/21993632 [accessed 2012 Mar 26]
41. I.J. Matouk, I. Abbasi, A. Hochberg, E. Galun, H. Dweik, and M. Akkawi Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis Eur J Gastroenterol Hepatol 21 6 2009 Jun 688 692
42. B. Mazumder, V. Seshadri, and P.L. Fox Translational control by the 3′-UTR: the ends specify the means Trends Biochem Sci 28 2 2003 Feb 91 98
43. E.E. McCarthy, J.T. Celebi, R. Baer, and T. Ludwig Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability Mol Cell Biol 23 14 2003 Jul 5056 5063
44. M.M. Murray, P.B. Mullan, and D.P. Harkin Role played by BRCA1 in transcriptional regulation in response to therapy Biochem Soc Trans 35 Pt 5 2007 Nov 1342 1346
45. S.P. Nana-Sinkam, and C.M. Croce MicroRNAs as therapeutic targets in cancer Transl Res 157 4 2011 Apr 216 225
46. L.B. Nguyen, S.J. Diskin, M. Capasso, K. Wang, M.A. Diamond, and J. Glessner Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci PLoS Genet 7 3 2011 Mar e1002026
47. K. Panzitt, M.M.O. Tschernatsch, C. Guelly, T. Moustafa, M. Stradner, and H.M. Strohmaier Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA Gastroenterology 132 1 2007 Jan 330 342
48. L. Poliseno, L. Salmena, J. Zhang, B. Carver, W.J. Haveman, and P.P. Pandolfi A coding-independent function of gene and pseudogene mRNAs regulates tumour biology Nature 465 7301 2010 Jun 24 1033 1038
49. K. Pollard, M. Hubisz, and A. Siepel Detection of non-neutral substitution rates on mammalian phylogenies Genome Res Oct 2009 gr.097857.109
50. C.P. Ponting, P.L. Oliver, and W. Reik Evolution and functions of long noncoding RNAs Cell 136 4 2009 629 641
51. M. Ratajska, E. Antoszewska, A. Piskorz, I. Brozek, A. Borg, and H. Kusmierek Cancer predisposing BARD1 mutations in breast-ovarian cancer families Breast Cancer Res Treat [Internet] 2011 Available from: http://www.ncbi.nlm.nih.gov/pubmed/21344236 [accesseded 2011 Aug 2]
52. S. Ryser, E. Dizin, C.E. Jefford, B. Delaval, S. Gagos, and A. Christodoulidou Distinct roles of BARD1 isoforms in mitosis: full-length BARD1 mediates Aurora B degradation, cancer-associated BARD1beta scaffolds Aurora B and BRCA2 Cancer Res 69 3 2009 Feb 1125 1134
53. R. Sabatier, J. Adélaïde, P. Finetti, A. Ferrari, L. Huiart, and H. Sobol BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancer Genes Chromosom Cancer 49 12 2010 1143 1151
54. S. Saini, S. Majid, S. Yamamura, Z.L. Tabatabai, S.O. Suh, and V. Shahryari Regulatory role of miR-203 in prostate cancer progression and metastasis Clin Cancer Res [Internet] 2010 Available from: http://www.ncbi.nlm.nih.gov/pubmed/21159887 [accessed 2011 Apr 13]
55. L. Salmena, L. Poliseno, Y. Tay, L. Kats, and P.P. Pandolfi A ceRNA hypothesis: the Rosetta stone of a hidden RNA language? Cell 146 3 2011 353 358
56. A. Siepel, G. Bejerano, J.S. Pedersen, A.S. Hinrichs, M. Hou, and K. Rosenbloom Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes Genome Res 15 8 2005 1034 1050
57. J.C. Sporn, T. Hothorn, and B.H. Jung BARD1 expression predicts outcome in colon cancer Clin Cancer Res [Internet] 2011 Available from: http://www.ncbi.nlm.nih.gov/pubmed/21693656 [accessed 2011 Jul 29]
58. L.M. Starita, and J.D. Parvin The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair Curr Opin Cell Biol 15 3 2003 345 350
59. K.L. Thu, R. Chari, W.W. Lockwood, S. Lam, and W.L. Lam miR-101 DNA copy loss is a prominent subtype specific event in lung cancer J Thorac Oncol 6 9 2011 1594 1598
60. M. Tsuzuki, W. Wu, H. Nishikawa, R. Hayami, D. Oyake, and Y. Yabuki A truncated splice variant of human BARD1 that lacks the RING finger and ankyrin repeats Cancer Lett 233 1 2006 108 116
61. S. Varambally, Q. Cao, R.-S. Mani, S. Shankar, X. Wang, and B. Ateeq Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer Science 322 5908 2008 1695 1699
62. G. Viticchiè, A.M. Lena, A. Latina, A. Formosa, L.H. Gregersen, and A.H. Lund MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines Cell Cycle 10 7 2011 1121 1131
63. M. Wakiyama, K. Takimoto, O. Ohara, and S. Yokoyama Let-7 microRNA-mediated mRNA deadenylation and translational repression in a mammalian cell-free system Genes Dev 21 15 2007 1857 1862
64. J. Wang, X. Liu, H. Wu, P. Ni, Z. Gu, and Y. Qiao CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer Nucleic Acids Res 38 16 2010 5366 5383
65. J. Wang, J. Zhang, H. Zheng, J. Li, D. Liu, and H. Li Mouse transcriptome: neutral evolution of "non-coding" complementary DNAs Nature 431 7010 2004 1 p following 757; discussion following 757
66. O. Wapinski, and H.Y. Chang Long noncoding RNAs and human disease Trends Cell Biol 21 6 2011 354 361
67. U. Wellner, J. Schubert, U.C. Burk, O. Schmalhofer, F. Zhu, and A. Sonntag The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs Nat Cell Biol 11 12 2009 1487 1495
68. U.K. Westermark, M. Reyngold, A.B. Olshen, R. Baer, M. Jasin, and M.E. Moynahan BARD1 participates with BRCA1 in homology-directed repair of chromosome breaks Mol Cell Biol 23 21 2003 7926 7936
69. J.E. Wilusz, H. Sunwoo, and D.L. Spector Long noncoding RNAs: functional surprises from the RNA world Genes Dev 23 13 2009 1494 1504
70. J.-Y. Wu, A.-T. Vlastos, M.-F. Pelte, M.-A. Caligo, A. Bianco, and K.-H. Krause Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis Int J Cancer 118 5 2006 1215 1226
71. L. Wu, J. Fan, and J.G. Belasco MicroRNAs direct rapid deadenylation of mRNA Proc Nat Acad Sci USA 103 11 2006 4034 4039
72. Y.-Q. Zhang, A. Bianco, A.M. Malkinson, V.P. Leoni, G. Frau, and N. De Rosa BARD1: an independent predictor of survival in non-small cell lung cancer Int J Cancer 131 1 2012 83 94
73. Y.-Q. Zhang, M. Pilyugin, D. Kuester, V.P. Leoni, L. Li, and G. Casula Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome Br J Cancer [Internet] 2012 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22814582 [accessed 2012 Jul 31]